Erector Spinae Plane Block Versus Serratus Plane Block for Breast Surgery

Ataturk University

Status: Completed

Conditions: Postoperative Pain; Breast Cancer

Treatments: Drug: Bupivacaine Hcl 0.25% Inj; Drug: Bupivacaine HCl Inj 0.25%

Study type: Interventional

Funder types: Other

Identifiers

NCT03538483

AUTFANESTHESIA

Details and patient eligibility

About

Serratus plane block (SPB) was first described in 2013 by Blanco and designed to primarily block the thoracic intercostal nerves. And this block provides sufficient analgesia lateral anterior and posterior part of thoracic wall.Erector Spinae Plane Block (ESPB) is a newly described and effective interfascial plane block for thoracic and abdominal surgery. It was first described by Forero et al. in 2016, effectiveness being reported in four cases. The aim of this study is to compare Serratus plane block and erector spinae plane block on postoperative pain in patients undergoing modified radical mastectomy and axillary lymph node dissection

Enrollment: 60 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• American Society of Anesthesiologist's physiologic state I-III patients
• undergoing breast cancer surgery
• 18-65 years

Exclusion criteria

• chronic pain
• bleeding disorders
• renal or hepatic insufficiency
• patients on chronic non-steroidal anti-inflammatory medications
• emergency cases
• coagulopathy

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

ultrasound guided serratus plane block

Active Comparator group

Description:

Ultrasound Guided Serratus Plane Block 30 ml %0.25 Bupivacaine

Treatment:

Drug: Bupivacaine Hcl 0.25% Inj

ultrasound guided erector spinae plane block

Active Comparator group

Description:

Ultrasound Guided Erector Spinae Plane Block 20 ml %0.25 Bupivacaine

Treatment:

Drug: Bupivacaine HCl Inj 0.25%